aceclofenac has been researched along with Acute Liver Injury, Drug-Induced in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Andrade, RJ; Gálvez, J; Hallal, H; Titos-Arcos, JC | 1 |
Alfonso Moreno, V; Roig Catalá, E; Zaragoza Marcet, A | 1 |
Hernández Beriain, J; Segura García, C | 1 |
Fernández González, MA; Fernández Ruiz, A; Pérez Moreno, JM; Puertas Montenegro, M | 1 |
Prieto de Paula, JM; Romero Castro, R; Villamandos Nicás, YV | 1 |
Fernández-Avala Novo, M; González Macías, J; Nan Nan, DN; Penado Nadela, S | 1 |
4 review(s) available for aceclofenac and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Aceclofenac-induced acute cholestatic lesion].
Topics: Acute Disease; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Diclofenac; Fatty Liver; HLA-B27 Antigen; Humans; Jaundice, Obstructive; Male; Middle Aged | 2010 |
[NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cholestasis; Diclofenac; Female; Humans; Male; Middle Aged | 1995 |
[Aceclofenac-induced hepatitis].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Humans | 1995 |
4 other study(ies) available for aceclofenac and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Toxic hepatitis caused by aceclofenac].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Humans; Male | 1996 |
[Hepatic toxicity caused by aceclofenac].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Humans; Time Factors | 1997 |
[Toxic hepatitis caused by aceclofenac].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Humans | 2001 |